JPRN-jRCT2080220019未知2 期
A phase 2 study of capecitabine (R340) in patients who have failed previous treatment with taxane for metastatic breast cancer.
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- Female
入选标准
- •1. Females
- •2. 20 and over Age and below 75
- •3. performance status 0-2,
- •4. Patients with a history of at least one regimen of chemotherapy including taxene (paclitaxel or docetaxel) (including (neo-) adjuvant therapy)
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Phase II study with capecitabine as monotherapy in the treatment of platinum resistant or refractory ovarian cancer - MITO-6EUCTR2006-001724-40-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE32
进行中（未招募）
不适用
Prospective phase II trial using Capecitabine and Trastuzumab for therapy of female patients with cerebral metastasizing, HER2-overexpressing breast cancer - HERXECNS-metastasizing HER2-overexpressing breast cancerMedDRA version: 9.1Level: PTClassification code 10057654Term: Breast cancer femaleMedDRA version: 9.1Level: PTClassification code 10006202Term: Breast cancer stage IVEUCTR2007-003634-42-DEKlinikum der Universität München, Standort Großhadern
已完成
不适用
Randomised phase II study comparing capecitabine with oral cyclophosphamide and capecitabine in patients with advanced breast cancerAdvanced breast cancerCancerBreast cancerISRCTN68662102Cancer Trials New Zealand (CTNZ) (New Zealand)82
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer - NDAdvanced or metastatic head and neck cancerLevel: HLTClassification code 10024530EUCTR2006-003775-13-ITOSPEDALE ONCOLOGICO DI BARI43
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer - NDEUCTR2006-003752-38-ITOSPEDALE ONCOLOGICO DI BARI